Interaction of materials and biology in total joint replacement - successes, challenges and future directions

被引:0
|
作者
Pajarinen, J. [1 ]
Lin, T. -H. [1 ]
Sato, T. [1 ]
Yao, Z. [1 ]
Goodman, S. B. [1 ,2 ]
机构
[1] Stanford Univ, Sch Med, Dept Orthopaed Surg, Orthopaed Surg Labs, Stanford, CA 94063 USA
[2] Stanford Univ, Dept Bioengn, Stanford, CA 94063 USA
关键词
TOTAL HIP-ARTHROPLASTY; NECROSIS-FACTOR-ALPHA; PARTICLE-INDUCED OSTEOLYSIS; ORTHOPEDIC WEAR PARTICLES; VIL-10; GENE-TRANSFER; IN-VITRO; PERIPROSTHETIC OSTEOLYSIS; TITANIUM PARTICLES; CHROMIUM IONS; POLYETHYLENE PARTICLES;
D O I
10.1039/c4tb01005a
中图分类号
TB3 [工程材料学]; R318.08 [生物材料学];
学科分类号
0805 ; 080501 ; 080502 ;
摘要
Total joint replacement (TJR) has revolutionized the treatment of end-stage arthritic disorders. This success is due, in large part, to a clear understanding of the important interaction between the artificial implant and the biology of the host. All surgical procedures in which implants are placed in the body evoke an initial inflammatory reaction, which generally subsides over several weeks. Thereafter, a series of homeostatic events occur leading to progressive integration of the implant within bone and the surrounding musculoskeletal tissues. The eventual outcome of the operation is dependent on the characteristics of the implant, the precision of the surgical technique and operative environment, and the biological milieu of the host. If these factors and events are not optimal, adverse events can occur such as the development of chronic inflammation, progressive bone loss due to increased production of degradation products from the implant (periprosthetic osteolysis), implant loosening or infection. These complications can lead to chronic pain and poor function of the joint reconstruction, and may necessitate revision surgery or removal of the prosthesis entirely. Recent advances in engineering, materials science, and the immunological aspects associated with orthopaedic implants have fostered intense research with the hope that joint replacements will last a lifetime, and facilitate pain-free, normal function.
引用
收藏
页码:7094 / 7108
页数:15
相关论文
共 50 条
  • [1] Computational Structural Biology: Successes, Future Directions, and Challenges
    Nussinov, Ruth
    Tsai, Chung-Jung
    Shehu, Amarda
    Jang, Hyunbum
    MOLECULES, 2019, 24 (03)
  • [2] Early experience with transcatheter mitral valve replacement: successes, challenges, and future directions
    Huded, Chetan P.
    Desai, Milind Y.
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S1008 - S1012
  • [3] A recent training initiative: Successes, challenges and future directions
    Knight, K.
    AUSTRALASIAN JOURNAL ON AGEING, 2009, 28 : A63 - A63
  • [4] Zoonotic Diseases in Oman: Successes, Challenges, and Future Directions
    Al Awaidy, Salah
    Al Hashami, Hilal
    VECTOR-BORNE AND ZOONOTIC DISEASES, 2020, 20 (01) : 1 - 9
  • [5] Cancer screening in Australia: successes, challenges and future directions
    Aranda, Sanchia
    Currow, David C.
    PUBLIC HEALTH RESEARCH & PRACTICE, 2019, 29 (02):
  • [6] Materials in total joint replacement
    Santavirta, S
    Konttinen, YT
    Lappalainen, R
    Anttila, A
    Goodman, SB
    Lind, M
    Smith, L
    Takagi, M
    Gómez-Barrena, E
    Nordsletten, L
    Xu, JW
    CURRENT ORTHOPAEDICS, 1998, 12 (01): : 51 - 57
  • [7] Total hip replacement: A successful interaction of biology, mechanics, and materials science
    Santavirta, S
    Goodman, SB
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2005, (430) : 2 - 2
  • [8] The Current State of Antimicrobial Stewardship: Challenges, Successes, and Future Directions
    Emberger, Jennifer
    Tassone, Dan
    Stevens, Michael P.
    Markley, J. Daniel
    CURRENT INFECTIOUS DISEASE REPORTS, 2018, 20 (09)
  • [9] Outcome Measures in Total Joint Arthroplasty: Current Status, Challenges, and Future Directions
    Halawi, Mohamad J.
    ORTHOPEDICS, 2015, 38 (08) : E685 - E689
  • [10] The Current State of Antimicrobial Stewardship: Challenges, Successes, and Future Directions
    Jennifer Emberger
    Dan Tassone
    Michael P. Stevens
    J. Daniel Markley
    Current Infectious Disease Reports, 2018, 20